Another selective PI3K inhibitor, 3-MA acts on Vps34 and PI3Kγ and significantly enhances IL-24-induced apoptosis in oral squamous cellcarcinomas (OSCC), which demonstrates the combination of autophagy inhibitors and IL-24 is a promising approach for tumor immunotherapy [178]. Here, IL24 is linked to neoplasm.